Only two previous studies propose that SENP2 reduces the proliferation of HCC cells through modulating β-catenin stability (14, 15), whereas whether SENP2 could affect stemness and sensitivity to targeted therapy in HCC remains unclear. This evidence concerns the gene SENP2 and hepatocellular carcinoma.